Adenocarcinoma of lung (disorder)
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma.
|
19040416 |
2009 |
Adenocarcinoma of lung (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
TTF-1 gene amplification has been discovered in a part of lung adenocarcinomas, and its action as a lineage-specific oncogene is highlighted.
|
19293183 |
2009 |
Adenocarcinoma of lung (disorder)
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component.
|
21036415 |
2011 |
Adenocarcinoma of lung (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
TTF-1 shows independent prognostic significance in advanced lung adenocarcinoma.
|
21799026 |
2012 |
Adenocarcinoma of lung (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
TTF1 amplification in lung adenocarcinomas was associated with pathologic subtypes (p = 0.029).
|
22011671 |
2012 |
Adenocarcinoma of lung (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Finally, we also show that MYBPH is epigenetically inactivated by promoter DNA methylation in a fraction of TTF-1-positive lung adenocarcinomas, which appears to be in accordance with its deleterious functions in lung adenocarcinoma invasion and metastasis, as well as with the paradoxical association of TTF-1 expression with favourable prognosis in lung adenocarcinoma patients.
|
22085929 |
2012 |
Adenocarcinoma of lung (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma.
|
22439932 |
2012 |
Adenocarcinoma of lung (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Conversely, TTF-1 counters epithelial to mesenchymal transition in cell-based studies and inhibits progression of primary lung adenocarcinomas to metastases in an animal model of lung adenocarcinomas.
|
22761434 |
2012 |
Adenocarcinoma of lung (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Cathepsin D expression was more frequent in TTF-1-negative than in TTF-1-positive ADs (P=0.034), and more frequent in ADs with EGFR wild genotype than mutant EGFR (P<0.001).
|
22824147 |
2012 |
Adenocarcinoma of lung (disorder)
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Although HNF4α was also expressed in other lung adenocarcinoma subtypes, those with HNF4α expression shared IMC features, including negative TTF-1 expression (P<0.001), positive CDX2 expression (P<0.001), positive KRAS mutation status (P=0.001), and negative EGFR mutation status (P<0.001).
|
23108025 |
2013 |
Adenocarcinoma of lung (disorder)
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Mucinous adenocarcinoma of the lung is a subtype of highly invasive pulmonary tumors and is associated with decreased or absent expression of the transcription factor NK2 homeobox 1 (NKX2-1; also known as TTF-1).
|
23143308 |
2012 |
Adenocarcinoma of lung (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
In this study we investigated the clinicopathologic characteristics associated with EGFR or TTF-1 amplification in lung adenocarcinomas and its prognostic significance.
|
23525704 |
2013 |
Adenocarcinoma of lung (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
Emerging evidence indicates that NKX2-1, a homeobox-containing transcription factor also known as TTF-1, plays a role as a "lineage-survival" oncogene in lung adenocarcinomas.
|
23763999 |
2013 |
Adenocarcinoma of lung (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
CK20 and CDX2 positivity supported metastatic pancreatic cancer, whereas TTF-1 positivity supported primary lung adenocarcinoma.
|
23887294 |
2014 |
Adenocarcinoma of lung (disorder)
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
When EZH2 and TTF-1 expressions are considered together, they serve as a prognostic marker in patients with surgically resected lung adenocarcinomas.
|
24097870 |
2013 |
Adenocarcinoma of lung (disorder)
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In clinical practice, TTF-1 expression combine with EGFR mutations, especially exon 21 mutation can guide clinical treatment timely for lung adenocarcinomas.
|
24743427 |
2014 |
Adenocarcinoma of lung (disorder)
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Consistent with ICC results, there was significant difference of TTF1 expression in the LAC and NLAC compared with IMP3 expression.
|
25337222 |
2014 |
Adenocarcinoma of lung (disorder)
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
The present study suggested that the combination of MUC5B and TTF-1 expression is useful for discriminating adenocarcinomas from squamous cell carcinomas, yielding prognostic significance in patients with lung adenocarcinoma.
|
25733373 |
2015 |
Adenocarcinoma of lung (disorder)
|
0.400 |
Biomarker
|
disease |
CTD_human |
The E3 ubiquitin ligase Trim7 mediates c-Jun/AP-1 activation by Ras signalling.
|
25851810 |
2015 |
Adenocarcinoma of lung (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
TTF1 reacted for only 20 (58.82%) of 34 cases of lung ACA.
|
25935651 |
2015 |
Adenocarcinoma of lung (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
TTF1- correlated with solid and invasive mucinous subtypes of lung adenocarcinoma and lower frequency of EGFR mutations.
|
26200450 |
2015 |
Adenocarcinoma of lung (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
The receptor tyrosine kinase-like orphan receptor 1 (ROR1) sustains prosurvival signalling directly downstream of the lineage-survival oncogene NKX2-1/TTF-1 in lung adenocarcinoma.
|
26725982 |
2016 |
Adenocarcinoma of lung (disorder)
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
KRAS mutation-positive bronchial surface epithelium (BSE)-type lung adenocarcinoma with strong expression of TTF-1: a case providing a further insight as for the role of TTF-1 in the oncogenesis.
|
26823891 |
2015 |
Adenocarcinoma of lung (disorder)
|
0.400 |
Biomarker
|
disease |
BEFREE |
In summary, this study provides evidence that TTF-1 may reprogram lung cancer secreted proteome into an antiangiogenic state, offering a novel basis to account for the long-standing observation of favorable prognosis associated with TTF-1(+) lung adenocarcinomas.
|
26912193 |
2016 |
Adenocarcinoma of lung (disorder)
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Contribution of ¹⁸Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung adenocarcinoma.
|
27062706 |
2016 |